Amedisys, Inc. (AMED) Misses Q1 EPS by 3c

Amedisys, Inc. (NASDAQ: AMED) reported Q1 EPS of ($0.07), $0.03 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $298.74 million versus the consensus estimate of $301.89 million.

For earnings history and earnings-related data on Amedisys, Inc. (AMED) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Sunstone Hotel Investors to sell Hyatt Regency San Francisco for $279M
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth